Your browser doesn't support javascript.
loading
Streptococcal Esophagitis in an Immunocompetent Patient: A Rare Sequelae.
Bathobakae, Lefika; Mekheal, Nader; Mücahit, Derya; Alkomos, Mina Fransawy; Farokhian, Alisa; Cavanagh, Yana; Baddoura, Walid.
Affiliation
  • Bathobakae L; St. Joseph's University Medical Center, Paterson, NJ, USA.
  • Mekheal N; St. Joseph's University Medical Center, Paterson, NJ, USA.
  • Mücahit D; Rowan University School of Osteopathic Medicine, Stratford, NJ, USA.
  • Alkomos MF; St. Joseph's University Medical Center, Paterson, NJ, USA.
  • Farokhian A; St. Joseph's University Medical Center, Paterson, NJ, USA.
  • Cavanagh Y; St. Joseph's University Medical Center, Paterson, NJ, USA.
  • Baddoura W; St. Joseph's University Medical Center, Paterson, NJ, USA.
J Investig Med High Impact Case Rep ; 12: 23247096241271985, 2024.
Article in En | MEDLINE | ID: mdl-39171694
ABSTRACT
Infectious esophagitis (IE) is the leading cause of esophagitis, second only to gastroesophageal reflux disease. Infectious esophagitis is typically observed in immunocompromised individuals due to neutropenia, HIV/AIDS, solid organ malignancies, cancer-directed therapy, or chronic steroid use. The most common causes of IE are herpes simplex virus (HSV), cytomegalovirus (CMV), and Candida albicans. Acute bacterial esophagitis is exceedingly rare, particularly in immunocompetent patients. Herein, we describe a unique case of acute streptococcal esophagitis in a male patient with no pertinent medical history. The patient's substernal chest pain and odynophagia resolved after antibiotic treatment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcal Infections / Esophagitis / Anti-Bacterial Agents Limits: Humans / Male Language: En Journal: J Investig Med High Impact Case Rep Year: 2024 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Streptococcal Infections / Esophagitis / Anti-Bacterial Agents Limits: Humans / Male Language: En Journal: J Investig Med High Impact Case Rep Year: 2024 Type: Article Affiliation country: United States